Kenfarb & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.07M Sell
3,860
-410
-10% -$211K 1.9% 12
2023
Q2
$2M Sell
4,270
-30
-0.7% -$12.6K 1.74% 16
2023
Q1
$1.48M Sell
4,300
-100
-2% -$33.7K 1.32% 25
2022
Q4
$1.61M Hold
4,400
1.43% 24
2022
Q3
$1.42M Buy
4,400
+40
+0.9% +$12.7K 1.35% 26
2022
Q2
$1.25M Hold
4,360
0.99% 30
2022
Q1
$1.25M Sell
4,360
-500
-10% -$129K 0.99% 30
2021
Q4
$1.34M Buy
+4,860
New +$1.23M 0.98% 31

Other funds holding LLY

Kenfarb & Co's LLY Position: Q3 2023 in Review

Kenfarb & Co reduced its Eli Lilly (LLY) stake by 9.6% in Q3 2023, selling an estimated $211K and leaving 3,860 shares worth $2.07M. The position accounts for 1.9% of the portfolio, ranked #12.

Kenfarb & Co first reported a position in LLY in Q4 2021 and has held it in 8 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Kenfarb & Co held 3,860 shares of Eli Lilly worth $2.07M as of Q3 2023.
  • Kenfarb & Co sold 410 Eli Lilly shares in Q3 2023, an estimated $211K.
  • Eli Lilly made up 1.9% of Kenfarb & Co's portfolio in Q3 2023, its #12 holding.
  • Kenfarb & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 8 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.